Navigation Links
Azantis Launches Liposomal Glutathione and Vitamin C.
Date:10/31/2011

BOULDER, Colo., Oct. 31, 2011 /PRNewswire/ -- Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.

The liposomal glutathione contains 500 mg reduced glutathione per recommended daily dose.  These liposomes are highly stable with a very tight particle size range.  These features optimize the bioavailability of the glutathione cargo.

Glutathione is the body's most important intracellular sulfur bearing antioxidant, and the body's prime defense against toxins and oxidation. Low glutathione blood levels are commonly associated with poor health.

The vitamin C liposomes are designed to minimize intestinal discomfort, since certain individuals have difficulty tolerating vitamin C therapy at the clinically relevant higher doses. The recommended daily dosage is 1,000 mg vitamin C.  The vitamin C, as well as the glutathione liposomal product, is in liquid form.

"Reduced glutathione in liposomal form is superior, because of the maximized absorption. Oral administration of supplemental liposomes, when compared to IV and injections, allows a more even dosing of once or possibly several times per day," said Mickey Schuett, Director of Sales at Azantis Inc. "These products target foremost health care practitioners and resellers that market to these practitioners. The potency of this advanced delivery form is less suitable for the direct to consumer market."

Consumer information about liposomal glutathione and liposomal vitamin C can be readily found on the internet.

About Azantis

Azantis is a biotech company located in Boulder, Colorado. The company specializes in discovery and extraction of bioactive molecules from sustainable marine and other biomass sources for use in food, nutraceutical, and pharmaceutical products. Azantis' product offerings include omega 3 phospholipids and phospholipid liposomes.

Contact Mickey Schuett, 303-502-2400 or http://www.azantis.com/contact-us/


'/>"/>
SOURCE Azantis
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Azantis Announces New Consumer Safety Program
2. Australias Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elektas Advanced 4D Motion Management Technology
3. Global Strategic Marketing Key to Success in Oncology Launches in the Pharmaceutical Sector
4. FHSSA Launches New Campaign to Partner US Hospices with Programs in Sub-Saharan Africa
5. nContact, Inc. Launches New Corporate Websites
6. First Response Launches IVF Fundraising Resource for Those Trying for a Baby
7. CDC Launches Effort to Protect Cancer Patients From Infections
8. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
9. Gamma Pharmaceuticals, Inc., Launches Retail Promotions for Gamma Energy Gel™ in New York City and Houston
10. Arthrosurface Launches Worlds First Talus Resurfacing Implant for the Ankle
11. DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):